-
Loading metrics
HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment
- Christoph Sarrazin,
- Michael Manns,
- Jose Luis Calleja,
- Javier Garcia-Samaniego,
- Xavier Forns,
- Renee Kaste,
- Xiaofei Bai,
- Jing Wu,
- Jerry O. Stern
x
- Published: December 28, 2016
- https://doi.org/10.1371/journal.pone.0168544